The N-acetyl variant is studied as a structurally stabilized tool compound for such investigations into cellular senescence, geroprotection, and peptide-receptor interactions
The peptide's ability to promote tissue healing may help maintain the therapeutic effects of these interventions
For further information, see: Peer group discussion: improving gout care This is a revision of a previously published article
This step is what makes everything following it perform better
"The Multifaceted Therapeutic Role of N-Acetylcysteine (NAC) in Disorders Characterized by Oxidative Stress." Curr Neuropharmacol
What they found: Oral AOD-9604 reduced body fat by 18 to 22 % vs placebo, comparable to injection administration No changes in total body weight (because lean mass rose slightly) Decrease in plasma triglycerides by 30 % Decrease in resting free fatty acids (paradoxically, mobilization of fat from depots into oxidation) No GI side effects Why it matters: It suggested that AOD-9604 could work orally , a rare property for a peptide